190 related articles for article (PubMed ID: 1501283)
1. Identification and characterization of fusion and processing domains of the human immunodeficiency virus type 2 envelope glycoprotein.
Freed EO; Myers DJ
J Virol; 1992 Sep; 66(9):5472-8. PubMed ID: 1501283
[TBL] [Abstract][Full Text] [Related]
2. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
Otteken A; Voss G; Hunsmann G
Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
[TBL] [Abstract][Full Text] [Related]
3. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion.
Broder CC; Berger EA
J Virol; 1993 Feb; 67(2):913-26. PubMed ID: 8419649
[TBL] [Abstract][Full Text] [Related]
4. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.
Thali M; Furman C; Helseth E; Repke H; Sodroski J
J Virol; 1992 Sep; 66(9):5516-24. PubMed ID: 1501286
[TBL] [Abstract][Full Text] [Related]
5. Studies on the role of the V3 loop in human immunodeficiency virus type 1 envelope glycoprotein function.
Chiou SH; Freed EO; Panganiban AT; Kenealy WR
AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1611-8. PubMed ID: 1457207
[TBL] [Abstract][Full Text] [Related]
6. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
Raja NU; Vincent MJ; Jabbar MA
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
[TBL] [Abstract][Full Text] [Related]
7. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.
Guo HG; Veronese FM; Tschachler E; Pal R; Kalyanaraman VS; Gallo RC; Reitz MS
Virology; 1990 Jan; 174(1):217-24. PubMed ID: 2104682
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41.
Freed EO; Myers DJ; Risser R
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4650-4. PubMed ID: 2191297
[TBL] [Abstract][Full Text] [Related]
9. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity.
Freed EO; Delwart EL; Buchschacher GL; Panganiban AT
Proc Natl Acad Sci U S A; 1992 Jan; 89(1):70-4. PubMed ID: 1729720
[TBL] [Abstract][Full Text] [Related]
10. Identification of conserved residues in the human immunodeficiency virus type 1 principal neutralizing determinant that are involved in fusion.
Freed EO; Risser R
AIDS Res Hum Retroviruses; 1991 Oct; 7(10):807-11. PubMed ID: 1720627
[TBL] [Abstract][Full Text] [Related]
11. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity.
Page KA; Stearns SM; Littman DR
J Virol; 1992 Jan; 66(1):524-33. PubMed ID: 1727497
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum.
Vincent MJ; Raja NU; Jabbar MA
J Virol; 1993 Sep; 67(9):5538-49. PubMed ID: 8350411
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120.
Freed EO; Martin MA
J Virol; 1994 Apr; 68(4):2503-12. PubMed ID: 8139032
[TBL] [Abstract][Full Text] [Related]
14. An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surface.
Sauter MM; Pelchen-Matthews A; Bron R; Marsh M; LaBranche CC; Vance PJ; Romano J; Haggarty BS; Hart TK; Lee WM; Hoxie JA
J Cell Biol; 1996 Mar; 132(5):795-811. PubMed ID: 8603913
[TBL] [Abstract][Full Text] [Related]
15. Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation.
Andeweg AC; Leeflang P; Osterhaus AD; Bosch ML
J Virol; 1993 Jun; 67(6):3232-9. PubMed ID: 7684463
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity.
Dubay JW; Roberts SJ; Brody B; Hunter E
J Virol; 1992 Aug; 66(8):4748-56. PubMed ID: 1629954
[TBL] [Abstract][Full Text] [Related]
17. Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins.
Berlioz-Torrent C; Shacklett BL; Erdtmann L; Delamarre L; Bouchaert I; Sonigo P; Dokhelar MC; Benarous R
J Virol; 1999 Feb; 73(2):1350-61. PubMed ID: 9882340
[TBL] [Abstract][Full Text] [Related]
18. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
Barbouche R; Decroly E; Kieny MP; Fenouillet E
Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
[TBL] [Abstract][Full Text] [Related]
19. A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity.
Salzwedel K; West JT; Hunter E
J Virol; 1999 Mar; 73(3):2469-80. PubMed ID: 9971832
[TBL] [Abstract][Full Text] [Related]
20. Role of the fusogenic peptide sequence in syncytium induction and infectivity of human immunodeficiency virus type 2.
Steffy KR; Kraus G; Looney DJ; Wong-Staal F
J Virol; 1992 Jul; 66(7):4532-5. PubMed ID: 1602558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
